CRISPR Therapeutics AG
NASDAQ:CRSP
CRISPR Therapeutics AG
NASDAQ:CRSP
Price:
50.34
USD
-3.19%
Market Closed
Market Cap:
$4.8B
Wall Street
Price Targets
CRSP Price Targets Summary
CRISPR Therapeutics AG
CRISPR Therapeutics AG
Wall Street analysts forecast CRSP stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
CRSP
is 82.91 USD
with a low forecast of 32.32 USD and a high forecast of 330.75 USD.
Lowest
Price Target
32.32
USD
36% Downside
Average
Price Target
82.91
USD
65% Upside
Highest
Price Target
330.75
USD
557% Upside
CRISPR Therapeutics AG Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRSP's stock price target?
Price Target
82.91
USD
82.91
USD
According to Wall Street analysts, the average 1-year price target for
CRSP
is 82.91 USD
with a low forecast of 32.32 USD and a high forecast of 330.75 USD.
What is CRISPR Therapeutics AG's Revenue forecast?
Projected CAGR
118%
118%
For the last 9 years the
compound annual growth rate for
CRISPR Therapeutics AG's revenue is
79%.
The projected
CAGR
for the next 4 years is
118%.
